SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950123-09-031691
Filing Date
2009-08-07
Accepted
2009-08-07 08:38:40
Documents
6
Period of Report
2009-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w75259e8vk.htm 8-K 13804
2 EX-10.1 w75259exv10w1.htm EX-10.1 38088
3 EX-99.1 w75259exv99w1.htm EX-99.1 40924
4 EX-99.2 w75259exv99w2.htm EX-99.2 4024
5 GRAPHIC w75259w7525902.gif GRAPHIC 10940
6 GRAPHIC w75259w7525901.gif GRAPHIC 7894
  Complete submission text file 0000950123-09-031691.txt   124780
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 09993601
SIC: 2836 Biological Products, (No Diagnostic Substances)